Disease | disseminated intravascular coagulation |
Phenotype | C0023418|leukemia |
Sentences | 9 |
PubMedID- 24217998 | Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin. |
PubMedID- 23559733 | [1–3] disseminated intravascular coagulation also occurs in patients with leukemia due to hypofibrinogenemia. |
PubMedID- 23943008 | The occurrence of hyperleukocytosis (leukocytes > 100.000/mul) is associated with complications such as leukostasis, tumor lysis and consumption coagulopathy in patients with acute leukemia much more often than in patients with chronic malignant hematological diseases. |
PubMedID- 19500934 | Background: hyperleukocytosis in acute leukemia is associated with lymphadenopathy, hepatosplenomegaly, disseminated intravascular coagulation, and central nervous system complications. |
PubMedID- 25934464 | Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy. |
PubMedID- 24762998 | This study was aimed to explore the clinical characteristics and optimal therapeutic methods for newly diagnosed acute promyelocytic leukemia (apl) combined with disseminated intravascular coagulation (dic) so as to guide the clinical therapy. |
PubMedID- 25759668 | We recently evaluated and performed vitrectomy in a child with severe massive vitreous hemorrhage due to secondary acute myelogenous leukemia (aml) associated with disseminated intravascular coagulation (dic) and tumor lysis syndrome. |
PubMedID- 22044440 | Case presentation: a 9 year-old male with acute lymphoblastic leukemia complicated by pancytopenia and disseminated intravascular coagulation was given platelet transfusion. |
PubMedID- 23291674 | Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution. |
Page: 1